Future of Diabetes Care Agenda

Download the Agenda
  • Day One | Thursday, July 18th, 2024
  • Day Two | Friday, July 19th, 2024
  • Co-Located Obesity Innovation Summit
Day One | Thursday, July 18th, 2024
8:00AM CST

Registration Opens: Breakfast & Networking

9:00AM CST

Chair’s Opening Remarks

9:10AM CST

Keynote Presentation: Exploring the Shifting Landscape of Diabetes Care & Management in the US

  • How can we go from Knowledgeable to Action? 
  • How will we stem the tide on diabetes and its complications?
  • Diabetes care is a team sport – How can digital health solutions become part of that team?

Speaker To Be Announced

9:35AM CST

Keynote Panel: Moving towards Patient-Centered, Multidisciplinary Diabetes Care & Management

  • What is the ideal composition of a well-rounded care team for those managing diabetes? 
  • What steps can be taken to implement educators, mental health professionals and dietitians as a standard practice of care? 
  • What case studies can demonstrate the benefits of multidisciplinary diabetes care? 
  • Why is shared decision making with patients on treatment and management plans becoming increasingly important? 
  • How can we ensure high standards of care amidst a diminishing workforce crisis in diabetes management? 
  • In  what ways can AI tools alleviate administrative burdens on healthcare providers?

Gregory Deines, Section Chief of Diabetes & Endocrinology, Corewell Health 
Bankim Bhatt, Chief, Department of Endocrinology & Metabolism, St Luke’s University Health Network
Anastasios Manessis, Medical Director, Endocrine Associates of West Village 

10:20AM CST

Morning Refreshments

10:50AM CST

Case Study Presentation: Embracing Patient Perspectives on the Diabetes Care Gap

  • What challenges have occurred during their diabetes journey?
  • How could diabetes care be improved from a patient’s point of view? 
  • How have the costs of diabetes management and the role of insurance companies influenced  their overall diabetes management?

Phyllisa Deroze,Patient Advocate & Director for Content Strategy, The Diabetes Research Company
Leola Collins, Patient & Diabetes Advocate

11:25AM CST

Presentation: Addressing the Cost of Diabetes Treatment

  • What are the current financial hurdles faced by patients and providers in obtaining affordable diabetes medication? 
  • What initiatives and measures have been implemented by pharmaceutical companies to reduce the soaring cost of insulin?
  • In what ways can collaboration among stakeholders bridge the gap between production cost and retail price to achieve more equitable pricing structures for advanced diabetes medication?

Stephen Ouellette, Senior Vice President, Diabetes Division, Byram Healthcare

11:50AM CST

Panel: Breaking Barriers to Patient Access Imposed by Insurance Policies

  • What restrictions do diabetes patients commonly face in accessing high quality diabetes care? 
  • What are the effects on patient outcomes when medication usage is dictated by insurance companies instead of physicians? 
  • How does the availability of essential diabetes technology differ across medicare, medicaid, and private insurance plans?
  • What measures can be taken to streamline the authorisation process for diabetes equipment and treatments?
  • What strategies can insurance companies adopt to expand coverage for a wider range of diabetes medication and technology?

Speakers To Be Announced

12:30PM CST

Lunch

2:00PM CST

Interactive Round Tables

During these intimate breakout sessions, attendees will have the opportunity to get hands on with the latest continuous glucose monitors and insulin pumps. Through immersive demonstrations, peer-to-peer learning, and live simulations of physician-patient interactions, these interactive sessions will offer attendees the opportunity to discover insights beyond what can be attained through presentations  to uncover and panel discussions alone. The topics in session A and B will remain the same,  allowing for participation in both sessions.

Round Table 1:

This session will focus on analyzing CGM data in practice and honing the skill of effectively communicating data results to patients. Using CGM data gathered from attendees throughout the day, learn how to maximize the value of CGM data via discussion and participation in various provider-patient scenarios performed live.

Andreas Stuhr, Formerly Vice President of Global Medical Affairs and Chief Medical Officer, Formerly Ascensia Diabetes Care 
Nicholas Argento, Diabetes Technology Director, Maryland Endocrine and Diabetes Center

Round Table 2:

In this session, we will delve into the pros and cons of the most well-known insulin pumps used across the US. Accompanied by insulin pump manufacturers, the session will feature comprehensive demonstrations illustrating the operation of each pump.

Speakers To Be Announced

2:30PM CST

Interactive Round Tables – Time to Swap!

Round Table 2:

In this session, we will delve into the pros and cons of the most well-known insulin pumps used across the US. Accompanied by insulin pump manufacturers, the session will feature comprehensive demonstrations illustrating the operation of each pump.

Speakers To Be Announced

Round Table 1:

This session will focus on analyzing CGM data in practice and honing the skill of effectively communicating data results to patients. Using CGM data gathered from attendees throughout the day, learn how to maximize the value of CGM data via discussion and participation in various provider-patient scenarios performed live.

Andreas Stuhr, Formerly Vice President of Global Medical Affairs and Chief Medical Officer, Formerly Ascensia Diabetes Care 
Nicholas Argento, Diabetes Technology Director, Maryland Endocrine and Diabetes Center

3:00PM CST

Afternoon Refreshments

4:10PM CST

Presentation: Optimizing Data Usage from Novel Diabetes Technologies

  • How can we unleash the full potential of data collected from new diabetes technology? 
  • How can we filter data collected from diabetes technology to improve glycemic outcomes?
  • How can we encourage patients to engage with suggestions deriving from data?

Jocelyne Karam, Director, Division of Endocrinology, Associate Professor of Medicine, Maimonides Medical Center

4:35PM CST

Panel Discussion: Utilizing Diabetes Care and Education Specialists

  • What education areas do diabetes educators cover for patients and physicians? 
  • How can diabetic educators ease the burden on primary care physicians? 
  • How can we move towards mandating automatic referrals to a diabetes educator from a physician for all diabetes patients? 
  • What changes need to be implemented to ensure every primary physician clinic has a diabetes educator?
  • With the majority of outpatient diabetes centers in hospitals having closed and the cases of diabetes rising,  how can we expand the role of diabetes educators to counteract the loss of comprehensive care from these centers? 
  • How can we increase reimbursement rates for diabetes educators to better reflect their value and impact?

Maria Patruno, Director, Diabetes Education Program, Endocrine Associates of West Village
Amy Huelle, Director of Diabetes Care Services, Maimonides Medical Center

5:20PM CST

Chairs Closing Remarks

5:30PM CST

Close of Future of Diabetes Care Summit Day 1

Download the Agenda
Day Two | Friday, July 19th, 2024
8:00AM CST

Registration, Breakfast & Networking

9:00AM CST

Chair’s Opening Remarks

9:10AM CST

Panel Discussion: Combating the Obesity Epidemic to Shield Against Type 2 Diabetes

  • To what extent can decreasing obesity impact the prevention of diabetes and mitigate diabetes-related healthcare expenses? 
  • What initiatives have the food industry taken to counteract the obesity crisis?
  • What benefits and drawbacks are associated with utilizing GLP-1 medications such as Mounjaro and Ozempic for diabetes management, given their notable potential for weight loss?
  • How effective are wearables in promoting proactive weight management as opposed to reactive weight loss in prediabetic and diabetic patients? 
  • What strategies can be employed systematically to counteract the obesity epidemic?

Shagun Bindlish, Mission Chair, American Diabetes Association

9:55AM CST

Presentation: Navigating the Psychosocial Dimensions of Diabetes Care

  • How does diabetes intersect with and contribute to elevated rates of anxiety and depression?
  • What role does counseling play in holistic diabetes care and management? 
  • How can we aid patients to implement realistic self-care and healthy behaviors amidst the challenges of busy lifestyles and burnout? 
  • How can technology be harnessed to provide support for anxiety disorders and depression among diabetic patients?

Speaker To Be Announced

10:25AM CST

Presentation Aligning Diabetes Care to Meet the Needs of Pregnancy

  • What are the current challenges in diabetes care for pregnant women in the US? 
  • What are the key components of a successful diabetes and pregnancy clinic that leverages collaborations between fetal medicine and endocrinology to enhance diabetes care during pregnancy? 
  • Why is there a lack of commercial diabetes products in the US that are specifically developed to meet the unique needs of diabetic pregnant women? What are some examples of diabetes technologies for pregnant women that exist globally but not in the US? 
  • What are the greatest opportunities for development in pregnancy-related diabetes care and management?

Speaker To Be Announced

10:50AM CST

Morning Refreshments

11:20AM CST

Presentation: Understanding the Emerging Demographic of Geriatric Type 1 Diabetics

  • What are the unique challenges in diabetes management for the geriatric type 1 diabetes population?
  • How does diabetes management differ between type 1 diabetes in younger individuals and in geriatric patients? 
  • What advances in technology have been particularly beneficial for geriatric type 1 diabetics?

Speaker To Be Announced

11:45AM CST

Fireside Chat: Distinguishing between Type 1 and Type 2 in Young People

  • How does type 2 diabetes present differently in children and adolescents compared with adults?
  • What are the difficulties in distinguishing between late onset type 1 and type 2 diabetes? How does this impact patient care?
  • How can Teplizumab be used to delay type 1 diabetes in children and adolescents and what are the subsequent benefits of delaying diabetes management?

Debra Franco, President & Co-Founder, South Texas Juvenile Diabetes Association
Ana Maria Paez, Medical Director & Pediatric Endocrinologist, Driscoll Health System

12:10PM CST

Closing Panel: Entering a New Era for Diabetes Care and Management

  • What are the potential advancements in adjective treatments for type 1 diabetes?
  • What are the emerging therapeutic options on the horizon for type 2 diabetes?
  • What developments are being made in biotechnology to prevent type 1 and identify autoimmune factors that contribute to the condition? 
  • What strategies need to be put into action to curb the impending diabetes epidemic?
  • What can be expected for the next phase of development for diabetes technology?

Esther Latres, Vice President of Research,  JDRF
Molly Dwyer-White, Managing Director, Caswell Diabetes Institute

12:50PM CST

Chair’s Closing Remarks

1:00PM CST

Close of Future of Diabetes Care Summit

Download the Agenda
Co-Located Obesity Innovation Summit

Double the Summits, double the content! Conveniently co-located at the Laura Hotel and running simultaneously, Obesity Innovation Summit delegate pass holders will be able to access all session and networking opportunities of the Future of Diabetes Care Summit on a complimentary basis.

View the agenda for the Obesity Innovation Summit